Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Tuberkuloz ve Toraks (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Tuberkuloz ve Toraks published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Respiratory Systemrank 86 of 107 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Tuberkuloz ve Toraks
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Tuberkuloz ve Toraks is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access.
02Fee waivers
APC waivers and discounts for Tuberkuloz ve Toraks
We have not found a published waiver policy for this journal's publisher (Ankara University). Ask the editorial office before you submit, and compare publishers that do waive the APC in the APC waiver checker.
Waivers apply to fully open access journals. If Tuberkuloz ve Toraks is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Tuberkuloz ve Toraks
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Tuberkuloz ve Toraks? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of Tuberkuloz ve Toraks
- ISSN
- 0494-1373
- Publisher
- Ankara University all its journals →
- Subjects
- Respiratory System
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Tuberkuloz ve Toraks
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Tuberkuloz ve Toraks accepts. You find it on the journal's website at Ankara University, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Tuberkuloz ve Toraks is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for Tuberkuloz ve Toraks
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Tuberkuloz ve Toraks, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
06Same subject
Respiratory System journals with a similar impact factor*
The journals next to Tuberkuloz ve Toraks when the 107 journals of Respiratory System in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 82 | Respirology Case Reports | 0.78 | ESCI | Fully open access |
| 83 | Canadian Respiratory Journal | 0.77 | SCIE | Fully open access |
| 84 | The Journal of Heart and Lung Transplantation | 0.77 | SCIE | Subscription |
| 85 | CHEST Journal | 0.76 | SCIE | Subscription |
| 87 | Asian Cardiovascular and Thoracic Annals | 0.75 | ESCI | Subscription |
| 88 | Pneumon | 0.73 | ESCI | Subscription |
| 89 | Sarcoidosis vasculitis and diffuse lung diseases | 0.71 | SCIE | Some open access |
| 90 | Monaldi Archives for Chest Disease | 0.71 | ESCI | Fully open access |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
07Journal Finder
Find the right journal for your paper
Is Tuberkuloz ve Toraks right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Tuberkuloz ve Toraks?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Tuberkuloz ve Toraks is 0.76: papers it published in the two previous years were cited 0.76 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Tuberkuloz ve Toraks?
The h-index of Tuberkuloz ve Toraks is 24 (OpenAlex, October 2026): 24 of its papers have each been cited at least 24 times. Its i10-index is 119.
What is the quartile of Tuberkuloz ve Toraks?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Tuberkuloz ve Toraks is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Tuberkuloz ve Toraks indexed in Scopus?
Tuberkuloz ve Toraks is not listed in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Tuberkuloz ve Toraks an SCIE journal?
Tuberkuloz ve Toraks is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Tuberkuloz ve Toraks in Journal Citation Reports (JCR)?
Yes. Tuberkuloz ve Toraks is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Who funds research published in Tuberkuloz ve Toraks?
0% of 69 recent research articles in Tuberkuloz ve Toraks name a funder in Crossref.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Magnetism and Magnetic Materials
- Langmuir
- Applied Surface Science
- Journal of Colloid and Interface Science
- International Journal of Hydrogen Energy
- Journal of Cleaner Production
- Remote Sensing
- Frontiers in Psychology
- Journal of Clinical Oncology
- Environmental Science and Pollution Research
- IEEE Access
- Journal of Organometallic Chemistry
- Molecules
- Sustainability
Browse all journals: indexing, impact factor and reviewer comments →